STRONG LONG-TERM RESULTS WITH CERAMENT®G FOR SEVERE OPEN FRACTURES – STUDY FROM MANCHESTER UNIVERSITY HOSPITAL bit.ly/3Oycq26

BONESUPPORT lanserar nästa generation av CERAMENT® G bit.ly/435EHAK

BONESUPPORT LAUNCHES NEXT GENERATION OF CERAMENT® G bit.ly/3NunoDy

BONESUPPORT HOLDING AB (PUBL) – INBJUDAN TILL KONFERENSSAMTAL OCH WEBBSÄNDNING FÖR DELÅRSRAPPORT Q2 2023 bit.ly/3XDp1TY

BONESUPPORT HOLDING AB (PUBL) – INVITATION TO CONFERENCE CALL AND WEBCAST FOR INTERIM REPORT Q2 2023 bit.ly/3D6g3oM

BONESUPPORT HOLDING AB (PUBL) – PUBLICERAR Q2 2023 DELÅRSRAPPORT bit.ly/43j2i0Z

BONESUPPORT HOLDING AB (PUBL) – PUBLISHES Q2 2023 INTERIM REPORT bit.ly/3XWSfNV

BONESUPPORT ERHÅLLER ”BREAKTHROUGH DEVICE DESIGNATION” FÖR CERAMENT® V FÖR INDIKATIONEN BENINFEKTION bit.ly/3PQ8mt2

BONESUPPORT RECEIVES “BREAKTHROUGH DEVICE DESIGNATION” FOR CERAMENT® V FOR THE INDICATION OF BONE INFECTION bit.ly/3PVW5n2

Today we published our Q3 Interim Report July – September 2023. bonesupport.com/en-eu/media/pr…

CERAMENT® G ERHÅLLER TRANSITIONAL PASS-THROUGH PAYMENT (TPT) bit.ly/3FMBwoc

CERAMENT® G APPROVED FOR TRANSITIONAL PASS-THROUGH PAYMENT (TPT) bit.ly/3QLafZF

CERAMENT® BONE VOID FILLER BEVILJAS INDIKATIONEN INTERBODY FUSION I SPINE bit.ly/3uZNuJs

CERAMENT® BONE VOID FILLER RECEIVES FDA CLEARANCE FOR SPINAL INTERBODY FUSION PROCEDURES Read the Press release here 👇 bit.ly/3Ip6fZT

CERAMENT® G ERHÅLLER MARKNADSGODKÄNNANDE FÖR ÖPPNA FRAKTURER bit.ly/3IBZMek

CERAMENT® G RECEIVES FDA CLEARANCE FOR OPEN FRACTURES bit.ly/4ceBrIS

BONESUPPORT HOLDING AB (PUBL) – PUBLICERAR Q1 2024 DELÅRSRAPPORT bit.ly/3UhA3gu

BONESUPPORT HOLDING AB (PUBL) – PUBLISHES Q1 2024 INTERIM REPORT bit.ly/4baM0vf

BONESUPPORT HOLDING AB (PUBL) – PUBLICERAR Q2 2024 DELÅRSRAPPORT bit.ly/3W1Kl5v

BONESUPPORT HOLDING AB (PUBL) – PUBLISHES Q2 2024 INTERIM REPORT bit.ly/3RYr3wz